Sarcoma trials in Israel
9 trials · From ClinicalTrials.gov, checked 10 November 2026. Ask the study team whether a trial fits you.
- Phase 1/2Taking peopleSubstudy 01A: Zilovertamab Vedotin in Pediatric and Young Adult Participants With Hematologic Malignancies or Solid Tumors (MK-9999-01A/LIGHTBEAM-U01)
- Where
- Haifa, Ramat Gan
- Age
- 6 months to 25 years
- People
- 90 worldwide
- Run by
- Merck Sharp & Dohme LLC
See details and how to joinNCT06395103 · EU 2023-507178-41-00 - Phase 1Taking peoplePhase I Study of [177Lu]Lu-DFC413 in Patients With Solid Tumors
- Where
- Haifa, Tel Aviv
- Age
- 18 years and over
- People
- 180 worldwide
- Run by
- Novartis Pharmaceuticals
See details and how to joinNCT07261631 - Phase 1/2Taking peopleA Study Evaluating the Efficacy and Safety of Risvutatug Rezetecan in Participants With Advanced Sarcomas (EMBOLD Sarcoma-202)
- Where
- Jerusalem, Tel Aviv
- People
- 64 worldwide
- Run by
- GlaxoSmithKline
See details and how to joinNCT07602777 - No phaseTaking peopleInternational Rare Brain Tumor Registry
- Where
- Haifa, Petah Tikva, Tel Aviv, Tel HaShomer
- Age
- Up to 45 years
- People
- 5,800 worldwide
- Run by
- Children's National Research Institute
See details and how to joinNCT05697874 - No phaseTaking peopleAlpha Radiation Emitters Device (DaRT) for the Treatment of Cutaneous, Mucosal or Superficial Soft Tissue Neoplasia
- Where
- Jerusalem
- Age
- 18 years and over
- People
- 56
- Run by
- Alpha Tau Medical LTD.
See details and how to joinNCT04534127 - No phaseNot yet taking people in IsraelAcupuncture as add-on to G-CSF for Febrile Neutropenia-related Hospitalization in Doxorubicin-treated Patients With Sarcoma
- Where
- Jerusalem
- Age
- 18 years to 65 years
- People
- 60
- Run by
- Shaare Zedek Medical Center
See details and how to joinNCT06500715 - No phaseTaking peopleAlpha Radiation Emitters Device (DaRT) for the Treatment of Cutaneous, Mucosal or Superficial Soft Tissue Neoplasia.
- Where
- Haifa
- Age
- 18 years and over
- People
- 30
- Run by
- Alpha Tau Medical LTD.
See details and how to joinNCT03889899 - Phase 1/2Taking peopleAnti-NY-ESO-1 TCR-Gene Engineered Lymphocytes Given by Infusion to Patients With NY-ESO-1 -Expressing Metastatic Cancers
- Where
- Jerusalem
- Age
- 18 years to 70 years
- People
- 3
- Run by
- Hadassah Medical Organization
See details and how to joinNCT05296564 - Phase 1/2Taking peopleFaR-RMS: An Overarching Study for Children and Adults With Frontline and Relapsed RhabdoMyoSarcoma
- Where
- Haifa, Jerusalem, Petah Tikva, Tel Aviv, Tel HaShomer
- People
- 1,672 worldwide
- Run by
- University of Birmingham
See details and how to joinNCT04625907 · EU 2024-510579-40-00